About HBiofluids
HBiofluids was established in 2002 in Milano, Italy, as a contract manufacturer in the medical fluids sector. Operations focused on producing haemofiltration solutions in PVC bags, priming and IV solutions in PVC or PVC-free containers, infusion systems with patented spikes, and CAPD systems for peritoneal dialysis. GMP-certified facilities were maintained. The company was acquired by Bellco in November 2013.
- Headquarter Milano, Italy
-
Email
Locked
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of HBiofluids
Detailed funding history for HBiofluids
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in HBiofluids
HBiofluids has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bellco.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Urban credit union
|
Locked | Locked | Locked |
Investor details for HBiofluids
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HBiofluids
Investment portfolio details for HBiofluids
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HBiofluids
Detailed financials for HBiofluids
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hbiofluids Comparisons
Peer comparison for HBiofluids
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HBiofluids
Detailed competitors of HBiofluids
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hbiofluids
Complete news archive for HBiofluids
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HBiofluids
HBiofluids was founded in 2002.
HBiofluids is headquartered in Milano, Italy.
Carlo Medici is the current CEO of HBiofluids.
HBiofluids was established in 2002 in Milano, Italy, as a contract manufacturer in the medical fluids sector. Operations focused on producing haemofiltration solutions in PVC bags, priming and IV solutions in PVC or PVC-free containers, infusion systems with patented spikes, and CAPD systems for peritoneal dialysis. GMP-certified facilities were maintained. The company was acquired by Bellco in November 2013.
HBiofluids has 1 investor. Key investors include Bellco.